Abhishek Patil

About

Consultant and Head Department of Rheumatology and Clinical immunology
Manipal hospitals, Bengaluru
Research interest: Rheumatic diseases and Pregnancy

Employment

• Manipal Hospitals Consultant
  2019 - Present
• Christian Medical College, Vellore Senior resident
  2018 - Present

Education

• Indraprastha Apollo Hospital DNB Trainee
  2015 - Present
• University College of Medical Sciences MD
  2011 - 2014
• Karnataka Institute of Medical Sciences MBBS
  2004 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• The efficacy of hypnosis in chronic low back pain: Protocol for a systematic review and meta-analysis of randomized controlled trials
  European Journal of Integrative Medicine 2026 DOI: 10.1016/j.eujim.2025.102605
  +Save
• Multifocal tuberculous myositis: a case series from a tuberculosis endemic region
  Journal of Rheumatic Diseases 2026 DOI: 10.4078/jrd.2025.0128
  +Save
• Relationship between hope, optimism, emotional regulation, and pain in fibromyalgia
  Clinical Rheumatology 2025 DOI: 10.1007/s10067-025-07742-z
  +Save
• Clinical profiling, treatment characteristics and outcome in Behcet’s Disease (BD)—A retrospective cohort study from Karnataka Rheumatology Association (KRA)
  Clinical Rheumatology 2024 DOI: 10.1007/s10067-024-07089-x
  +Save
• Rhabdomyolysis in a Case of Mild Coronavirus Disease 2019 and β-Thalassemia Minor.
  The Journal of the Association of Physicians of India 2024 DOI: 10.59556/japi.72.0612
  +Save
• A rare case of temporal arteritis in a young Indian male
  Indian Journal of Rheumatology 2023 DOI: 10.4103/injr.injr_108_22
  +Save
• Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort
  Lupus 2023 DOI: 10.1177/09612033231155837
  +Save
• Impact of COVID-19 on Rheumatic Diseases in India: Determinants of Mortality and Adverse Outcome: A Retrospective, Cross-Sectional Cohort Study
  Indian Journal of Rheumatology 2023 DOI: 10.4103/injr.injr_278_21
  +Save
• Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset.
  BMC rheumatology 2023 DOI: 10.1186/s41927-023-00345-8
  +Save
• Do Tofacitinib Generics Exhibit Conventional Synthetic Disease-Modifying Anti-rheumatic Drug and Non-steroidal Anti-inflammatory Drug-Sparing Ability in the Management of Axial Spondyloarthritis?
  Cureus 2023 DOI: 10.7759/cureus.46391
  +Save